Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion type Assertion NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_head.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion description "[However, mCP-CML, but not mBC-CML, relied on expression of programmed death-1 ligands 1 and 2 (PD-L1/L2) to resist T cell killing, because only GVL against mCP-CML was augmented when leukemias lacked PD-L1/L2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_provenance.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion evidence source_evidence_literature NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_provenance.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion SIO_000772 21768400 NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_provenance.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion wasDerivedFrom befree-20140225 NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_provenance.
- NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_assertion wasGeneratedBy ECO_0000203 NP227001.RAxrr03Mk05QLnqnjyqGX239D0u9p_CB02JbRribPm4SM130_provenance.